Literature DB >> 12202634

Concerning the CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis.

Heather Spencer Feigelson, Roberta McKean-Cowdin, Brian E Henderson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12202634     DOI： 10.1093/mutage/17.5.445

Source DB:  PubMed          Journal:  Mutagenesis        ISSN： 0267-8357            Impact factor:   3.000


× No keyword cloud information.
  4 in total

1.  Genetic variation in CYP17A1 and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California.

Authors:  Eric J Duell; Elizabeth A Holly; Karl T Kelsey; Paige M Bracci
Journal:  Int J Cancer       Date:  2010-02-01       Impact factor: 7.396

Review 2.  Epidemiology of estrogen and dementia in women with Down syndrome.

Authors:  Nicole Schupf; Joseph H Lee; Deborah Pang; Warren B Zigman; Benjamin Tycko; Sharon Krinsky-McHale; Wayne Silverman
Journal:  Free Radic Biol Med       Date:  2017-08-31       Impact factor: 8.101

3.  CYP17 gene polymorphism in relation to breast cancer risk: a case-control study.

Authors:  Kristjana Einarsdóttir; Tove Rylander-Rudqvist; Keith Humphreys; Susanne Ahlberg; Gudrun Jonasdottir; Elisabete Weiderpass; Kee Seng Chia; Magnus Ingelman-Sundberg; Ingemar Persson; Jianjun Liu; Per Hall; Sara Wedrén
Journal:  Breast Cancer Res       Date:  2005-09-14       Impact factor: 6.466

4.  CYP17 5'-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case-control study.

Authors:  Emaculate Verla-Tebit; Shan Wang-Gohrke; Jenny Chang-Claude
Journal:  Breast Cancer Res       Date:  2005-04-12       Impact factor: 6.466
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.